These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9260793)

  • 1. Iron overload in patients with chronic viral hepatitis: how common is it?
    Riggio O; Montagnese F; Fiore P; Folino S; Giambartolomei S; Gandin C; Merli M; Quinti I; Violante N; Caroli S; Senofonte O; Capocaccia L
    Am J Gastroenterol; 1997 Aug; 92(8):1298-1301. PubMed ID: 9260793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
    Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
    Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.
    Bayraktar Y; Saglam F; Temizer A; Uzunalimodlu B; van Thiel DH
    Hepatogastroenterology; 1998; 45(24):2322-7. PubMed ID: 9951916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy.
    Tsai NC; Zuckerman E; Han SH; Goad K; Redeker AG; Fong TL
    Am J Gastroenterol; 1997 Oct; 92(10):1831-4. PubMed ID: 9382046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
    Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
    J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
    Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
    Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in serum ferritin level in a patient with HCV hepatitis and liver hemosiderosis by interferon-alpha.
    Kawada E; Shinonome S; Tamura J; Murakami H
    J Med; 1994; 25(6):388-92. PubMed ID: 7769377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
    Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
    Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
    Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
    J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
    Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
    Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
    Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
    Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment].
    Bolewska B; Wojtacha A; Juszczyk J; Przedwojewski M
    Pol Merkur Lekarski; 2005 May; 18(107):552-5. PubMed ID: 16161954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serologic response against hepatitis C virus as a predictive factor to the treatment with interferon].
    Garrido A; Lepe JA; Guerrero FJ; Palomo S
    Enferm Infecc Microbiol Clin; 2000 Dec; 18(10):512-5. PubMed ID: 11198002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.